Resultats globals: 4 registres trobats en 0.01 segons.
Articles, 4 registres trobats
Articles 4 registres trobats  
1.
24 p, 1.4 MB Ischaemic conditioning and targeting reperfusion injury : a 30 year voyage of discovery / Hausenloy, Derek J. (National Heart Research Institute Singapore) ; Barrabés, José A.. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Bøtker, Hans Erik (Aarhus University Hospital (Aarhus, Dinamarca)) ; Davidson, Sean M. (University College London) ; Di Lisa, Fabio (University of Padova, Italy) ; Downey, James (University of South Alabama, Mobile) ; Engstrom, Thomas (Copenhagen University Hospital) ; Ferdinandy, Péter (Pharmahungary Group, Szeged, Hungary) ; Carbrera-Fuentes, Hector A. (Kazan Federal University, Russian Federation) ; Heusch, Gerd (University of Essen Medical School, Germany) ; Ibanez, Borja (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Iliodromitis, Efstathios K. (National and Kapodistrian University of Athens, Greece) ; Inserte, Javier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Jennings, Robert (Duke University, Durham, NC USA) ; Kalia, Neena (University of Birmingham, UK) ; Kharbanda, Rajesh (Oxford University Hospitals, UK) ; Lecour, Sandrine (University of Cape Town, South Africa) ; Marber, Michael (St. Thomas' Hospital, London, UK) ; Miura, Tetsuji (Sapporo Medical University School of Medicine, Japan) ; Ovize, Michel (Université Claude Bernard, Lyon 1, France) ; Perez-Pinzon, Miguel A. (University of Miami Miller School of Medicine, USA) ; Piper, Hans Michael (Carl von Ossietzky Universität Oldenburg) ; Przyklenk, Karin (Wayne State University, Detroit, USA) ; Schmidt, Michael Rahbek (Duke-National University of Singapore) ; Redington, Andrew (Cincinnati Children's Hospital Medical Center) ; Ruiz Meana, Marisol (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Vilahur, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Vinten-Johansen, Jakob (Emory University, Atlanta, USA) ; Yellon, Derek M. (The National Institute of Health Research University College London Hospitals Biomedical Research Centre, London, UK) ; García-Dorado, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
To commemorate the auspicious occasion of the 30th anniversary of IPC, leading pioneers in the field of cardioprotection gathered in Barcelona in May 2016 to review and discuss the history of IPC, its evolution to IPost and RIC, myocardial reperfusion injury as a therapeutic target, and future targets and strategies for cardioprotection. [...]
2016 - 10.1007/s00395-016-0588-8
Basic Research in Cardiology, Vol. 111 (october 2016)  
2.
13 p, 498.1 KB Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST-segment elevation myocardial infarction / Bøtker, Hans Erik (Aarhus University Hospital (Aarhus, Dinamarca)) ; Cabrera-Fuentes, H. A. (Kazan (Volga Region) Federal University) ; Ruiz Meana, Marisol (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Heusch, Gerd (University of Essen) ; Ovize, Michel (Université de Lyon)
Pre-clinical studies have indicated that mitoprotective drugs may add cardioprotection beyond rapid revascularization, antiplatelet therapy and risk modification. We review the clinical efficacy of mitoprotective drugs that have progressed to clinical testing comprising cyclosporine A, KAI-9803, MTP131 and TRO 40303. [...]
2020 - 10.1111/jcmm.14953
Journal of Cellular and Molecular Medicine, Vol. 24 (january 2020) , p. 2717-2729  
3.
11 p, 337.7 KB Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction : trials and tribulations / Hausenloy, Derek J. (National Institute of Health Research University College London Hospitals Biomedical Research Centre, London W1T 7DN, UK) ; Botker, Hans Erik (Aarhus University Hospital (Aarhus, Dinamarca)) ; Engstrom, Thomas (Copenhagen University Hospital Rigshospitalet) ; Erlinge, David (Department of Cardiology, Lund University, Lund, Sweden) ; Heusch, Gerd (Institute for Pathophysiology, West German Heart and Vascular Center, University of Essen Medical School, Essen, Germany) ; Ibanez, Borja (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Kloner, Robert A. (Division of Cardiovascular Medicine, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA) ; Ovize, Michel (UMR 1060 (CarMeN), Université Claude Bernard, Lyon, France) ; Yellon, Derek M. (National Institute of Health Research University College London Hospitals Biomedical Research Centre, London W1T 7DN, UK) ; García-Dorado, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
2016 - 10.1093/eurheartj/ehw145
European heart journal, Vol. 38 (april 2016) , p. 935-941  
4.
13 p, 340.4 KB ESC working group cellular biology of the heart : position paper: improving the preclinical assessment of novel cardioprotective therapies / Lecour, Sandrine (Hatter Institute for Cardiovascular Research (Àfrica)) ; Bøtker, Hans Erik (Aarhus University Hospital (Aarhus, Dinamarca)) ; Condorelli, Gianluigi (Instituto Clinico Humanitas (Milano, Itàlia)) ; Davidson, Sean M. (Hatter Institute for Cardiovascular Research (Londres, Regne Unit)) ; García-Dorado, David (Universitat Autònoma de Barcelona) ; Engel, Felix B. (Friedrich-Alexander-Universität Erlangen-Nürnberg) ; Ferdinandy, Péter (Semmelweis Egyetem. Department of Pharmacology and Pharmacotherapy) ; Heusch, Gerd (Universitätsklinikum Essen) ; Madonna, Rosalinda (Università degli Studi "G. d'Annunzio" Chieti) ; Ovize, Michel (Université Claude Bernard Lyon 1) ; Ruiz Meana, Marisol (Hospital Universitari Vall d'Hebron) ; Schulz, Rainer (Justus Liebig-Universität Gießen) ; Sluijter, Joost P. G. (Universitair Medisch Centrum Utrecht) ; Van Laake, Linda W. (Universitair Medisch Centrum Utrecht) ; Yellon, Derek M. (Hatter Institute for Cardiovascular Research (Londres, Regne Unit)) ; Hausenloy, Derek J. (Hatter Institute for Cardiovascular Research (Londres, Regne Unit))
Ischaemic heart disease (IHD) remains the leading cause of death and disability worldwide. As a result, novel therapies are still needed to protect the heart from the detrimental effects of acute ischaemia-reperfusion injury, in order to improve clinical outcomes in IHD patients. [...]
2014 - 10.1093/cvr/cvu225
Cardiovascular research, Vol. 104, issue 3 (Dec. 2014) , p. 399-411  

Vegeu també: autors amb noms similars
1 Ovize, M.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.